Fever following administration of two inactivated influenza vaccines-A survey of parents of New Zealand infants and children 5 years of age and under

Vaccine

Volumn 29, Issue 16, 2011, Pages 2933-2937

  Petousis Harris, Helen ^a   Poole, Tracey ^a   Booy, Robert ^b   Turner, Nikki ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Influenza vaccine; Vaccine reactogenicity; Vaccine safety

Indexed keywords

INFLUENZA VACCINE; PARACETAMOL;

ARTICLE; CHILD; DRUG FEVER; HEALTH SURVEY; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; NEW ZEALAND; OUTCOME ASSESSMENT; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT RESPONSE;

CHILD, PRESCHOOL; FEVER; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MENTAL RECALL; NEW ZEALAND; PARENTS; QUESTIONNAIRES; VACCINES, INACTIVATED;

EID: 79953230130     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.012     Document Type: Article

References (9)

1. Fetveit A. Assessment of febrile seizures in children. European Journal of Pediatrics 2008, 167:17-27.
2. Michael Marcy S., Kohl K.S., Dagan R., Nalin D., Blum M., Jones M.C., et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004, 22(5-6):551-556.
3. Tapiainen T., Heininger U. Fever following immunization. Expert Review of Vaccines 2005, 4(3):419-427.
4. Peltola H., Heinonen O.P. Frequency of true adverse reactions to measles-mumps-rubella vaccine A double-blind placebo-controlled trial in twins. Lancet 1986, 1(8487):939-942.
5. Jefferson T., Rivetti A., Harnden A., Di Pietrantonj C., Demicheli V. Vaccines for preventing influenza in healthy children [update of Cochrane Database Syst Rev. 2006;(1):CD004879; PMID: 16437500]. Cochrane Database of Systematic Reviews 2008, 2:CD004879.
6. Nolan T., Richmond P.C., McVernon J., Skeljo M.V., Hartel G.F., Bennet J., et al. Safety and immunogenicity of an inactivated thiomersal-free influenza vaccine in infants and childnren. Influenza and Other Respiratory Viruses 2009, 3:315-325.
7. Englund J.A., Walter E., Black S., Blatter M., Nyberg J., Ruben F.L., et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. The Pediatric Infectious Disease Journal 2010, 29(2):105-110. 10.1097/INF.0b013e3181b84c34.
8. Englund J.A., Walter E.B., Gbadebo A., Monto A.S., Zhu Y., Neuzil K.M. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006, 118(September (3)):e579-e585.
9. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. New England Journal of Medicine 2007, 356(February (7)):685-696.